デフォルト表紙
市場調査レポート
商品コード
1017191

頸動脈ステントの世界市場(2021年~2028年)

Global Carotid Stent Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.65円
頸動脈ステントの世界市場(2021年~2028年)
出版日: 2021年06月30日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

頸動脈ステント市場の成長を推進する主な要因には、心血管疾患などの疾患の有病率の上昇、バイパス手術を受ける高齢人口の増加、低侵襲手術の採用の増加、心臓病の研究開発イニシアチブの急増、技術の進歩などが挙げられます。

ステントは、血管の狭窄や障害を回避または中和するために、多くの国で冠動脈や末梢の処置の一部として使用されてきました。このようなステントの使用は効果的であるものの、欠点や懸念も存在します。再狭窄、すなわちインターベンション治療後に血管の狭窄が再発することは、血管内の異物に対する身体の正常な反応の典型的な症状です。

薬剤溶出性ステント(DES)は、再狭窄のリスクを大幅に低減することで、より良い臨床結果をもたらします。企業の市場売上を増加させるためには、生分解性ステントや分岐型ステントなど、DESの新たな改良が必要です。BiosensorsやAbbottなどの企業は、生分解性ステントや分岐型ステントを開発し、長期にわたるデバイスの埋め込みによって引き起こされる血栓症の問題に対処しています。

当レポートは、世界の頸動脈ステント市場について調査しており、市場の機会や影響、成長および抑制要因、COVID-19による影響、材料・タイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 世界の頸動脈ステントの調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界の頸動脈ステント市場-市場の定義と概要

第3章 世界の頸動脈ステント市場-エグゼクティブサマリー

  • 材料別の市場内訳
  • タイプ別の市場内訳
  • エンドユーザー別の市場内訳
  • 地域別の市場内訳

第4章 世界の頸動脈ステント市場-市場力学

  • 市場に影響を与える要因
    • 成長要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の頸動脈ステント市場-業界分析

  • ポーターのファイブフォース分析
  • PEST分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 世界の頸動脈ステント市場-COVID-19分析

  • 市場でのCovid-19の分析
    • COVID-19以前の市場シナリオ
    • 現在の市場シナリオ
    • COVID-19以後または今後のシナリオ
  • Covid-19における価格動向
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の頸動脈ステント市場-材料別

  • イントロダクション
    • 市場規模分析および前年比成長分析
    • 市場魅力指数
  • 金属
    • コバルトクロム
    • プラチナクロム
    • ニッケルチタン
    • ステンレス鋼
  • その他のステント

第8章 世界の頸動脈ステント市場-タイプ別

  • イントロダクション
    • 市場規模分析および前年比成長分析
    • 市場魅力指数
  • 自己拡張型ステント
  • バルーン拡張型ステント

第9章 世界の頸動脈ステント市場-エンドユーザー別

  • イントロダクション
    • 市場規模分析および前年比成長分析
    • 市場魅力指数
  • 病院
  • 外来手術センター
  • 心臓センター

第10章 世界の頸動脈ステント市場-地域別

  • イントロダクション
    • 市場規模分析(2018-2028)、および前年比成長分析(2020-2028)
    • 市場魅力指数
  • 北米
    • イントロダクション
    • 主要地域別の力学
    • 材料別:市場規模分析、および前年比成長分析
    • タイプ別:市場規模分析、および前年比成長分析
    • エンドユーザー別:市場規模分析、および前年比成長分析
    • 国別:市場規模分析、および前年比成長分析
  • 欧州
    • イントロダクション
    • 主要地域別の力学
    • 材料別:市場規模分析、および前年比成長分析
    • タイプ別:市場規模分析、および前年比成長分析
    • エンドユーザー別:市場規模分析、および前年比成長分析
    • 国別:市場規模分析、および前年比成長分析
  • 南米
    • イントロダクション
    • 主要地域別の力学
    • 材料別:市場規模分析、および前年比成長分析
    • タイプ別:市場規模分析、および前年比成長分析
    • エンドユーザー別:市場規模分析、および前年比成長分析
    • 国別:市場規模分析、および前年比成長分析
  • アジア太平洋
    • イントロダクション
    • 主要地域別の力学
    • 材料別:市場規模分析、および前年比成長分析
    • タイプ別:市場規模分析、および前年比成長分析
    • エンドユーザー別:市場規模分析、および前年比成長分析
    • 国別:市場規模分析、および前年比成長分析
  • 中東とアフリカ
    • イントロダクション
    • 主要地域別の力学
    • 材料別:市場規模分析、および前年比成長分析
    • タイプ別:市場規模分析、および前年比成長分析
    • エンドユーザー別:市場規模分析、および前年比成長分析

第11章 世界の頸動脈ステント市場-競合情勢

  • 主な発展と戦略
  • 企業シェア分析
  • 製品のベンチマーク
  • 注目すべき主要企業
  • 革新的技術を持つ企業
  • スタートアップ企業

第12章 世界の頸動脈ステント市場-企業プロファイル概要

  • Boston Scientific Corporation
    • 企業概要
    • 製品ポートフォリオ・概要
    • 要点
    • 財務概要
  • Abbott Laboratories
  • Cardinal Health
  • Medtronic Plc
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • W. L. Gore & Associates
  • BIOTRONIK SE & Co. KG
  • InspireMD
  • Impulse Dynamics
  • Shanghai Hengfei Biological Technology Co., Ltd
  • Beijing Bomais Technology Development
  • Shanghai Zhenyu Biological Technology Co., Ltd
  • Shanghai Haoran Biotechnology Co., Ltd

第13章 世界の頸動脈ステント市場-DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMMD3501

Market Overview

The global carotid stent market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Carotid stents are the medical devices placed in the carotid artery to remove the plaque formed. Stents placed in the carotid artery decrease the risk of stroke by widening the narrowed carotid artery and thus regulating a continuous blood flow.

Market Dynamics

The carotid stent market growth is driven by the rise in prevalence of diseases such as cardiovascular diseases, growing geriatric population with bypass surgery, rising adoption of minimally invasive procedures, the surge in research and development initiatives for heart diseases, and increasing technological advancements are the major factors driving the carotid stents market.

Increasing technological advancements, is expected to drive the global carotid stent market growth

For a considerable time, stents have been used as a part of coronary and peripheral procedures in many countries to avoid or neutralize the narrowing and hindering of vessels. The utilization of these stents has been effective; they are not without downsides and concerns. Restenosis, or the reoccurrence of vessel narrowing after the interventional procedure, is a typical symptom of a body's normal reaction to a foreign particle in the vasculature.

The drug-eluting stents (DES) result in better clinical outcomes by reducing the risk of restenosis significantly. New improvements in DES, such as biodegradable and bifurcated stents, are required to increase the market value of a company. Organizations like Biosensors and Abbott create biodegradable and bifurcated stents to manage issues of thrombosis, which is caused by long-term device implantation.

Rising demand for minimally invasive procedures, is expected to drive the global carotid stent market growth

The demand for minimally invasive procedures has been rapidly increasing globally. MI procedures reduce the physical injury risk and the chances of an infection, thereby enabling patients to have a more convenient and quicker recovery. MI procedures have certain advantages, such as affordable cost and shorter hospital stays. These methods have shown better outcomes than traditional methods.

MI procedures for heart diseases involve the insertion of delicate instruments through a small incision. Patients treated with these technologies can expect lesser discomfort and scarring and quicker recuperation than conventional surgeries. MI procedures have helped in the effective management of a few infections. These have also allowed specialists to make substantially smaller incisions.

Stringent approval processes is likely to hinder the market growth

Approval processes in many of the counties are very stringent for carotid stents. As these are to be introduced in the body, they fall under Class II and III devices, and it involves lots of time and investment for the approval of stent systems. For instance, recently, Boston Scientific SYNERGY Stent gained PMA approval after years of clinical trials. According to Advanced Medical Technology Association, it is estimated that about 77% and 80% of the total cost incurred in bringing a class II and class III medical device, respectively, to market is spent on FDA-linked approval stages.

Complications associated with stents is likely to hamper the market growth

According to the European Society of Cardiology, the potential procedural and peri-procedural complications that may be related to carotid angioplasty and stenting may be categorized as minor or major complications, including

Carotid artery spasm, Sustained, hypotension/bradycardiaCarotid artery dissection, Contrast encephalopathy (infrequent), Minor embolic neurological events (TIAs) are the major complications and minor complications like Major embolic stroke, Intracranial hemorrhage, Hyperperfusion syndrome, Carotid perforation (very rare), Acute stent thrombosis (very rare), Complications at the site of the vascular access.

COVID-19 Impact Analysis

The COVID-19 pandemic continues to endanger global health and hinder the world economy; It has been widely observed that patients with existing cardiovascular diseases experience higher complications due to COVID-19. Specifically, it has been found that patients with hypertension, diabetes and other comorbidities are at higher risk of death from the virus. During the widespread COVID-19 pandemic, there have been worries about the potential of specific procedures. The Centers for Disease Control and Prevention (CDC) and the European Society of Cardiology (ESC), and its council on hypertension have released position statements saying "we should not be jumping to conclusions and should not be withholding life-saving therapies from patients." More importantly, two very recent studies attest that blood pressure drugs and their associated minimally invasive procedures do not increase coronavirus risk. Some of these factors are driving the market growth in the forecast period.

Segment Analysis

The self-epanding stents segment is expected to hold largest share in this market segment

Self-expanding stents (SE) are of high elasticity but apply low radial outward force, allowing them to regain their shape after the compression force reduces, and has higher trackability, thus is easier to maneuver through tortuous vessels or pass the aortic bifurcation from the contralateral approach. For instance, Abbott conducting a study (superiority trial) to compare the Supera Peripheral Stent System with a standard nitinol self-expanding stent for treatment of femoro-popliteal arterial occlusive disease is expected to complete by 2023.

The nitinol segment is expected to hold largest share in this market segment

The nitinol segment served the largest share of the market. Nitinol is also known as nickel-titanium alloy, contains nearly an equal amount of nickel and titanium. Therefore, it has significant applications in medical devices where its unique properties allow minimally invasive surgery and implants to improve the quality of life for people. Moreover, its significant properties, such as nonmagnetic, corrosion resistance, biocompatible, and heat resistance, better flexibility have further boosted the market growth.

The most widely used material for self-expandable stents is nitinol. Self-expandable stents are advantageous because minor damage to the vessel is caused by low pressure while the stent is dilated. Moreover, self-expandable stents are beneficial for complex lesions as they can be securely implanted without using a balloon.

The hospital segment is expected to hold largest share in this market segment

The hospital segment held the largest share in the carotid stent market. This is mainly owing to increasing number of patients suffering from conditions which are treated in hospitals equipped with advanced infrastructure and adequate facilities. Also, the demand for products like carotid stents from these hospitals is increasing due to the rising awareness about the benefits of leading a better and healthy life. Moreover, growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment.

Geographical Analysis

North America region holds the largest market share of global carotid stent market

North America held the global market share due to factors such as the large population base, growing prevalence of cardiovascular diseases, rising adoption of advanced technologies. For instance, Adopting a sedentary lifestyle has severe implications for people's health and is known to cause diseases related to cardiovascular diseases, obesity, high blood pressure, etc. According to the World Health Organization, around about 60% - 85% of people worldwide have adopted a sedentary life. According to Centre for Disease Control and Prevention, around 31 million adults aged over 50 years lives a sedentary life, and only 1 out of 4 U.S. adults & 1 out five school student meets the guideline of physical activity. Heart disease is one of most leading causes of death in the U.S.; at least one person dies every 37 seconds due to cardiovascular disease, as reported by the Centre for Disease Control and Prevention. North American governments are taking measures to improve healthcare outcomes and reduce hospital expenditures; the adoption of advanced high-end technologies, world-class infrastructure and awareness regarding drug therapies is helping to expand the market in this region.

Competitive Landscape

The global carotid stent market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Medtronic Plc, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, BIOTRONIK SE & Co. KG, InspireMD, and Impulse Dynamics, Shanghai Hengfei Biological Technology Co., Ltd., Beijing Bomais Technology Development, Shanghai Zhenyu Biological Technology Co., Ltd, Shanghai Haoran Biotechnology Co., Ltd. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, On May 3 2021, Medtronic Announced CE Mark of Evolut™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe. The Evolut platform design, the PRO+ valve is designed with a self-expanding nitinol frame that conforms to the native annulus with consistent radial force and advanced sealing.

Carotid Stent Market Key Companies to Watch

Boston Scientific Corporation

Overview: The company was founded in 1979. It has headquarters in United States. It develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology, and neuromodulation. Globally the company has business in US, EMEA, Asia-Pacific, Latin America and Canada.

Product Portfolio: The company works through the segments MedSurg which includes Endoscopy, Urology and Pelvic health, Rhythm and Neuro, Cardiovascular, Specialty pharmaceuticals.

Product: The REBEL Stent System is the newest advance in bare-metal stent technology. REBEL Stent has the visibility you want from its PtCr alloy, the strength that need with the lowest recoil* and greatest radial strength, and the outstanding deliverability.

Key Developments: On Nov 2, 2020, Boston Scientific announced it has received U.S. Food and Drug Administration (FDA) approval of the Ranger™ Drug-Coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).

Why Purchase the Report?

  • Visualize the composition of the carotid stent market segmentation by type, material, end-user and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in carotid stent market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of carotid stent market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global carotid stent market report would provide an access to an approx. 61 market data table, 50 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Carotid Stent Market - By Type

  • Balloon-Expandable Stents
  • Self-Expanding Stents

Global Carotid Stent Market - By Material

  • Metals

Cobalt Chromium

Platinum Chromium

Nickel Titanium

Stainless Steel

  • Other Stents

Global Carotid Stent Market - By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers

Global Carotid Stent Market - By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Table of Contents

1. Global Carotid Stent Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Carotid Stent Market - Market Definition and Overview

3. Global Carotid Stent Market - Executive Summary

  • 3.1. Market Snippet by Material
  • 3.2. Market Snippet by Type
  • 3.3. Market Snippet by End-user
  • 3.4. Market Snippet by Region

4. Global Carotid Stent Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing technological advancements
      • 4.1.1.2. Rising demand for minimally invasive procedures
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent approval processes
      • 4.1.2.2. Complications associated with stents
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Carotid Stent Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Carotid Stent Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Carotid Stent Market - By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 7.1.2. Market Attractiveness Index, By Material Segment
  • 7.2. Metals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 7.2.3. Cobalt Chromium
    • 7.2.4. Platinum Chromium
    • 7.2.5. Nickel Titanium
    • 7.2.6. Stainless Steel
  • 7.3. Other stents

8. Global Carotid Stent Market - By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Self-Expanding Stents*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Balloon-Expandable Stents

9. Global Carotid Stent Market - By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
    • 9.1.2. Market Attractiveness Index, By End-user Segment
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Cardiac Centers

10. Global Carotid Stent Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

11. Global Carotid Stent Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. Key Companies to Watch
  • 11.5. Company with disruptive technology
  • 11.6. Start Up Companies

12. Global Carotid Stent Market- Company Profiles

  • 12.1. Boston Scientific Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Abbott Laboratories
  • 12.3. Cardinal Health
  • 12.4. Medtronic Plc
  • 12.5. Terumo Corporation
  • 12.6. MicroPort Scientific Corporation
  • 12.7. W. L. Gore & Associates
  • 12.8. BIOTRONIK SE & Co. KG
  • 12.9. InspireMD
  • 12.10. Impulse Dynamics
  • 12.11. Shanghai Hengfei Biological Technology Co., Ltd
  • 12.12. Beijing Bomais Technology Development
  • 12.13. Shanghai Zhenyu Biological Technology Co., Ltd
  • 12.14. Shanghai Haoran Biotechnology Co., Ltd

LIST NOT EXHAUSTIVE

13. Global Carotid Stent Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us